Atento S.A. Ordinary Shares (ATTO)

Sep 02, 2026

Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update - GlobeNewswire

Sep 02, 2026

Aug 28, 2026

Goldman units trade Attovia Therapeutics (ATTO) shares, add swaps - Stock Titan

Aug 28, 2026

Aug 28, 2026

Goldman to sell $2.2M in Attovia Therapeutics (ATTO) stock - Stock Titan

Aug 28, 2026

Aug 20, 2026

Atento S.A. (OTC: ATTOF) Stock Price, News & Analysis - kalkine.ca

Aug 20, 2026

Aug 13, 2026

Goldman Sachs entities (NYSE: ATTO) report Attovia stock conversions and market-making trades - Stock Titan

Aug 13, 2026

Aug 11, 2026

Frazier Life Sciences XI Discloses Investment at Attovia Therapeutics with 13.5% Stake - tradingview.com

Aug 11, 2026

Aug 11, 2026

Frazier Life Sciences funds (ATTO) detail Attovia stakes and IPO purchases - Stock Titan

Aug 11, 2026

Aug 10, 2026

Attovia Therapeutics (ATTO) insider reports initial stock and option holdings - Stock Titan

Aug 10, 2026

Aug 10, 2026

Attovia Therapeutics (ATTO) major holder converts 18.2M preferred into common - Stock Titan

Aug 10, 2026

Aug 10, 2026

Attovia Therapeutics (ATTO) director discloses 72,792-share option grant and vesting terms - Stock Titan

Aug 10, 2026

Aug 09, 2026

ATTO SEC FilingsAttovia Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Aug 09, 2026

Aug 08, 2026

Attovia Therapeutics (ATTO) CMO Hubert Chen discloses stock and option positions - Stock Titan

Aug 08, 2026

Aug 06, 2026

Attovia Therapeutics (Nasdaq:ATTO)Stock Analysis - Simply Wall Street

Aug 06, 2026

Aug 06, 2026

Attovia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - finance.yahoo.com

Aug 06, 2026

Aug 05, 2026

Attovia Therapeutics Prices Upsized $289 Million Initial Public Offering - Quiver Quantitative

Aug 05, 2026

Aug 05, 2026

Attovia Therapeutics prices IPO at $17 per share on Nasdaq By Investing.com - Investing.com Nigeria

Aug 05, 2026

Aug 05, 2026

Attovia Therapeutics prices IPO at $17 per share on Nasdaq - Investing.com India

Aug 05, 2026

Aug 04, 2026

Attovia Therapeutics prices upsized IPO at $17 per share - Investing.com

Aug 04, 2026

Aug 04, 2026

Attovia's 17M-share IPO is expected to begin Nasdaq Global Market trading Aug. 5 - Stock Titan

Aug 04, 2026

Aug 04, 2026

Attovia Therapeutics prices IPO at $17 per share on Nasdaq - Investing.com

Aug 04, 2026

Aug 04, 2026

Redmile Group (ATTO) reports Series B preferred stake convertible into 782,854 shares - Stock Titan

Aug 04, 2026

Jul 31, 2026

Funding Roundup: Braveheart, Attovia, Vogenx All Announce IPO’s - Pharmaceutical Executive

Jul 31, 2026

Jul 30, 2026

Braveheart Bio, Attovia seek $275M and $182M in U.S. IPOs - Seeking Alpha

Jul 30, 2026

Jul 24, 2026

Attovia Therapeutics Begins IPO Effort On Promising Early Trials (ATTO) - Seeking Alpha

Jul 24, 2026

Jul 14, 2026

Attovia Therapeutics files for IPO on Nasdaq - Investing.com

Jul 14, 2026

Jul 14, 2026

Attovia Therapeutics files for IPO on Nasdaq By Investing.com - Investing.com Nigeria

Jul 14, 2026

Apr 21, 2026

Atento SA stock (LU0992182062): Why Google Discover changes matter more now - AD HOC NEWS

Apr 21, 2026

Apr 19, 2026

Atento SA stock (LU0992182062): Why mobile-first delivery now matters more for customer experience i - AD HOC NEWS

Apr 19, 2026

Mar 15, 2026

Atento SA Stock (ISIN: LU0992182062) Faces Uncertainty Amid Sparse Market Activity - AD HOC NEWS

Mar 15, 2026

Jul 15, 2016

Attovia Therapeutics, Inc. (ATTO) Stock Price, News, Quote & History - Yahoo Finance

Jul 15, 2016

May 24, 1998

Upcoming and recent IPOs – IPOs calendar - Yahoo Finance Australia

May 24, 1998